It can also be seen that the efficacy of dupilumab is not closely related to the reduction in IgE values; in fact, these remain above normal in patients with EAD despite an optimal clinical response in terms of both the EASI and pruritus reduction [15]. Here, IGHE is linked to Pruritus.